mRNA vaccines

mRNA vaccines

featured image of Revolutionary RNA Production Tech Promises Faster Therapies!

Revolutionary RNA Production Tech Promises Faster Therapies!

BIOT

🔬 Quotient Sciences installs a state-of-the-art GMP Biofoundry-in-a-Box for automated RNA production, revolutionizing therapy development! 🚀🌱💡📈

featured image of Revolutionizing mRNA Production: Key Innovations Ahead!

Revolutionizing mRNA Production: Key Innovations Ahead!

BIOT

🚀 Discover how innovations in mRNA manufacturing post-COVID-19 are transforming vaccine production with efficiency and reliability! 💉🔬 Biologics Innovation

featured image of Revolutionizing mRNA: A Breakthrough in Biologics!

Revolutionizing mRNA: A Breakthrough in Biologics!

BIOT

🌟 Discover how Ginkgo Bioworks and TriLink BioTechnologies are revolutionizing mRNA manufacturing for better vaccines and therapeutics! 🚀🔬💡

featured image of Powering Up for Future Pandemics: 80M Vaccines!

Powering Up for Future Pandemics: 80M Vaccines!

BIOT

🌍 Wacker Biotech is ready to combat future pandemics with a new mRNA facility in Halle, Germany, producing 80 million doses! 💉🛠️

featured image of Agilent's $925M Biovectra Buy: Boosting Growth!

Agilent’s $925M Biovectra Buy: Boosting Growth!

BIOT

Agilent is acquiring Biovectra for $925M! 💰 This deal enhances CDMO services, especially in mRNA and gene editing. 🚀📦

featured image of Revolutionizing mRNA Vaccines: Faster Scalable and Effective!

Revolutionizing mRNA Vaccines: Faster Scalable and Effective!

BIOT

📚 Advancing mRNA Vaccine and Therapy Development discusses progress in mRNA vaccines and therapies, highlighting cell-free cloning for gene synthesis. 🧬💉

featured image of Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!

Wacker Biotech Unveils €100m RNA Manufacturing Site: Creating Jobs and Expanding Expertise!

BIOT

📢 German CDMO Wacker Biotech opens €100m RNA manufacturing site, creating 100 jobs and expanding expertise in RNA active ingredients. 💪🌍

featured image of French Company Receives $6m Grant to Fight Malaria

French Company Receives $6m Grant to Fight Malaria

BIOT

📢 French company Medincell Corp awarded $6m grant by Unitaid to fund safety testing of its malaria vaccine mdc-STM. 🌍🦟

featured image of Boost mRNA Manufacturing with Digital Optimization

Boost mRNA Manufacturing with Digital Optimization

BIOT

📰 Researchers in Germany developed a digital model to optimize mRNA manufacturing, resulting in increased production and reduced truncation. 💻💉

featured image of The High Costs of Low-Quality Albumin: Risks and Solutions

The High Costs of Low-Quality Albumin: Risks and Solutions

BIOT

1. 🚫💉 The Hidden Costs of Sub-standard Recombinant Albumin: Lost batches and patient risks in vaccines and biopharmaceuticals. 💰💊 2. The Hidden Costs of Sub-standard Recombinant Albumin: Safely lowering prices and broadening access to premium albumin. 💡💉🌾🔬🔍